CStone Pharmaceuticals Reports 2019 Annual Financial Results
- Written by ACN Newswire - Press Releases
HONG KONG, Mar 26, 2020 - (ACN Newswire) - CStone Pharmaceuticals ("CStone"; Stock Code: 2616.HK), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and molecularly-targeted precision medicines for the treatment of cancer, today released its audited annual financial results for
Read more //?#